[HTML][HTML] Recent advances in immunotherapy for hepatocellular carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - Cancers, 2020 - mdpi.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai… - …, 2020 - pubmed.ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

Recent Advances in Immunotherapy for Hepatocellular Carcinoma.

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - Cancers, 2020 - europepmc.org
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

[PDF][PDF] Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - pdfs.semanticscholar.org
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

[HTML][HTML] Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - Cancers, 2020 - ncbi.nlm.nih.gov
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - Cancers, 2020 - cir.nii.ac.jp
抄録< jats: p> Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-
related death since most patients are diagnosed at advanced stage and the current systemic …

[PDF][PDF] Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - researchgate.net
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

[PDF][PDF] Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - 2020 - core.ac.uk
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

S Nakano, Y Eso, H Okada, A Takai… - …, 2020 - repository.kulib.kyoto-u.ac.jp
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …

Recent Advances in Immunotherapy for Hepatocellular Carcinoma.

S Nakano, Y Eso, H Okada, A Takai, K Takahashi… - …, 2020 - search.ebscohost.com
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death since
most patients are diagnosed at advanced stage and the current systemic treatment options …